Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


Revenue 2017


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Perjeta was produced by Roche.

Roche's Perjeta should be 'new standard' in breast cancer

Roche's Perjeta should be 'new standard' in breast cancer Adding Roche's Perjeta to therapy with Herceptin and docetaxel has a dramatic impact on survival in patients with HER2-positive metastatic breast cancer, according to new trial data. ... With the latest CLEOPATRA data in hand the argument for the

Dive in: gaining leadership in a therapeutic area

Dive in: gaining leadership in a therapeutic area neu (4B5) Rabbit Monoclonal Primary Antibody assay marketed by its subsidiary Ventana - used to detect breast cancer patients eligible for Herceptin, Perjeta and Kadcyla.

Back to the future

Back to the future In 2013, Roche's biologics sales totalled $29.2bn. These were led by established oncology brands such as Avastin and MabThera/Rituxan, along with emerging breast cancer therapies such as Perjeta

NICE rejects Roche's Kadcyla as "unaffordable"

NICE rejects Roche's Kadcyla as The company is facing the threat of biosimilar competition to Herceptin later this year and had its Perjeta (pertuzumab) breast cancer drug rejected by NICE in draft guidance published in 2013.

Pharma's winners and losers in 2013

Pharma's winners and losers in 2013 well as emerging therapies such as breast cancer therapies Perjeta (pertuzumab) and Kadcyla (trastuzumab emtansine).

[ Previous 5 results ] 6 7 8 9 10 11 12 13 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts


Add my company

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...